Buprenorphine (Buvidal®)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1M
- Sector
- HEALTH
- Published
- 02 Jul 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 1 buyers and 1 suppliers
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- Camurus Lund
Description
Supply of Buprenorphine injections (Buvidal®) to NHS Scotland.
Total Quantity or Scope
Supply of Buprenorphine injections (Buvidal®)to NHS Scotland.
Award Detail
| 1 | Camurus (Lund)
|
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
As of July 2021 Buvidal® is the only prolonged-release buprenorphine injectable product available in the UK, manufactured by Camurus U.K. with no other current competition on the market.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The total value in Sections II.1.7 and V.2.4 refers to the twenty(20) months initial period and the total twenty eight (28) months extension period. (SC Ref:657013)
Reference
- ocds-h6vhtk-02c2e5
- FTS 015218-2021